Published guidance, NICE advice and quality standards | Guidance

Showing 541 to 550 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs	TA445	24 May 2017	24 May 2017
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine	TA440	26 April 2017	26 April 2017
Ixekizumab for treating moderate to severe plaque psoriasis	TA442	26 April 2017	26 April 2017
Obeticholic acid for treating primary biliary cholangitis	TA443	26 April 2017	26 April 2017
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)	TA438	29 March 2017	29 March 2017
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)	TA240	14 December 2011	29 March 2017
Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal)	TA436	22 March 2017	22 March 2017
Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal)	TA437	22 March 2017	22 March 2017
Elotuzumab for previously treated multiple myeloma (terminated appraisal)	TA434	22 March 2017	22 March 2017
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal)	TA435	22 March 2017	22 March 2017